| pubmed-article:11350094 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11350094 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11350094 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
| pubmed-article:11350094 | lifeskim:mentions | umls-concept:C0878544 | lld:lifeskim |
| pubmed-article:11350094 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:11350094 | lifeskim:mentions | umls-concept:C1293122 | lld:lifeskim |
| pubmed-article:11350094 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
| pubmed-article:11350094 | lifeskim:mentions | umls-concept:C0428772 | lld:lifeskim |
| pubmed-article:11350094 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:11350094 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:11350094 | pubmed:dateCreated | 2001-5-14 | lld:pubmed |
| pubmed-article:11350094 | pubmed:abstractText | The prognosis of patients with severe non-ischaemic dilated cardiomyopathy is variable. The predictive value of currently utilized tests is suboptimal. The purpose of this study was to determine the prognostic value of dobutamine-induced augmentation of left ventricular ejection fraction in patients with non-ischaemic dilated cardiomyopathy. | lld:pubmed |
| pubmed-article:11350094 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11350094 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11350094 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11350094 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11350094 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11350094 | pubmed:month | May | lld:pubmed |
| pubmed-article:11350094 | pubmed:issn | 0195-668X | lld:pubmed |
| pubmed-article:11350094 | pubmed:author | pubmed-author:SladeMM | lld:pubmed |
| pubmed-article:11350094 | pubmed:author | pubmed-author:WackersF JFJ | lld:pubmed |
| pubmed-article:11350094 | pubmed:author | pubmed-author:RamahiT MTM | lld:pubmed |
| pubmed-article:11350094 | pubmed:author | pubmed-author:VallejoEE | lld:pubmed |
| pubmed-article:11350094 | pubmed:author | pubmed-author:RohlfsKK | lld:pubmed |
| pubmed-article:11350094 | pubmed:author | pubmed-author:LongoM DMD | lld:pubmed |
| pubmed-article:11350094 | pubmed:author | pubmed-author:CadariuA RAR | lld:pubmed |
| pubmed-article:11350094 | pubmed:author | pubmed-author:CarolanSS | lld:pubmed |
| pubmed-article:11350094 | pubmed:copyrightInfo | Copyright 2001 The European Society of Cardiology. | lld:pubmed |
| pubmed-article:11350094 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11350094 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:11350094 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11350094 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11350094 | pubmed:pagination | 849-56 | lld:pubmed |
| pubmed-article:11350094 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:meshHeading | pubmed-meshheading:11350094... | lld:pubmed |
| pubmed-article:11350094 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11350094 | pubmed:articleTitle | Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy. | lld:pubmed |
| pubmed-article:11350094 | pubmed:affiliation | Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA. | lld:pubmed |
| pubmed-article:11350094 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11350094 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11350094 | lld:pubmed |
